ADRIANNA PLISZKA: Open Payments
NPI 1780266593 · GLASTONBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 46 payments from 10 companies in 2025. Trend: 2023 $2,138 · 2024 $1,109 · 2025 $1,010
Food & beverage: $1,000Education: $10
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 6 | $222 |
| GENZYME CORPORATION | 8 | $202 |
| ABBVIE INC. | 8 | $193 |
| Janssen Biotech, Inc. | 13 | $175 |
| Organon LLC | 3 | $66 |
| Galderma Laboratories, L.P. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| LEO Pharma Inc. | 2 | $30 |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, VTAMA, NEMLUVIO, TALTZ, Rhapsido, ADBRY.
Industry payments across CT — which companies pay providers there.
